Karen Todd Lane

Title(s)Health Sciences Professor, Surgery
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-8505
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern. Blood Adv. 2022 Apr 20. Li M, Beck EJ, Laeyendecker O, Eby Y, Tobian AA, Caturegli P, Wouters C, Chiklis GR, Block W, McKie RO, Joyner MJ, Wiltshire TD, Dietz AB, Gniadek TJ, Shapiro AS, Yarava A, Lane K, Hanley DF, Bloch EM, Shoham S, Cachay ER, Meisenberg BR, Huaman MA, Fukuta Y, Patel B, Heath SL, Levine AC, Paxton JH, Anjan S, Gerber JM, Gebo KA, Casadevall A, Pekosz A, Sullivan DJ. PMID: 35443020; PMCID: PMC9023079.
      View in: PubMed   Mentions:
    2. Early Outpatient Treatment for Covid-19 with Convalescent Plasma. N Engl J Med. 2022 Mar 30. Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. PMID: 35353960.
      View in: PubMed   Mentions:
    3. How do I implement an outpatient program for the administration of convalescent plasma for COVID-19? Transfusion. 2022 Mar 29. Bloch EM, Tobian AAR, Shoham S, Hanley DF, Gniadek TJ, Cachay ER, Meisenberg BR, Kafka K, Marshall C, Heath SL, Shenoy A, Paxton JH, Levine A, Forthal D, Fukuta Y, Huaman MA, Ziman A, Adamski J, Gerber J, Cruser D, Kassaye SG, Mosnaim GS, Patel B, Metcalf RA, Anjan S, Reisler RB, Yarava A, Lane K, McBee N, Gawad A, Raval JS, Zand M, Abinante M, Broderick PB, Casadevall A, Sullivan D, Gebo KA. PMID: 35352362.
      View in: PubMed   Mentions:
    4. High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern. medRxiv. 2022 Mar 02. Li M, Beck EJ, Laeyendecker O, Eby Y, Tobian AA, Caturegli P, Wouters C, Chiklis GR, Block W, McKie R, Joyner M, Wiltshire TD, Dietz AB, Gniadek TJ, Shapiro A, Yarava A, Lane K, Hanley D, Bloch EM, Shoham S, Cachay ER, Meisenberg BR, Huaman MA, Fukuta Y, Patel B, Heath SL, Levine AC, Paxton JH, Anjan S, Gerber JM, Gebo KA, Casadevall A, Pekosz A, Sullivan DJ, CSSC group. PMID: 35262085; PMCID: PMC8902868.
      View in: PubMed   Mentions:
    5. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21. Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. PMID: 34981068; PMCID: PMC8722611.
      View in: PubMed   Mentions:
    6. Post-Stroke Depression in Patients with Large Spontaneous Intracerebral Hemorrhage. J Stroke Cerebrovasc Dis. 2021 Nov; 30(11):106082. Avadhani R, Thompson RE, Carhuapoma L, Yenokyan G, McBee N, Lane K, Ostapkovich N, Stadnik A, Awad IA, Hanley DF, Ziai WC. PMID: 34517296; PMCID: PMC8532502.
      View in: PubMed   Mentions:
    7. Response of the trial innovation network to the COVID-19 pandemic. J Clin Transl Sci. 2021 Apr 20; 5(1):e100. Greenberg RG, Poole L, Ford DE, Hanley D, Selker HP, Lane K, Dean JM, Burr J, Harris P, Wilkins CH, Bernard G, Edwards T, Benjamin DK. PMID: 34192055; PMCID: PMC8185427.
      View in: PubMed   Mentions:
    8. Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH Trials. Neurosurgery. 2021 04 15; 88(5):961-970. Polster SP, Carrión-Penagos J, Lyne SB, Gregson BA, Cao Y, Thompson RE, Stadnik A, Girard R, Money PL, Lane K, McBee N, Ziai W, Mould WA, Iqbal A, Metcalfe S, Hao Y, Dodd R, Carlson AP, Camarata PJ, Caron JL, Harrigan MR, Zuccarello M, Mendelow AD, Hanley DF, Awad IA. PMID: 33475732; PMCID: PMC8190461.
      View in: PubMed   Mentions:
    9. Enhancing the Informed Consent Process Using Shared Decision Making and Consent Refusal Data from the CLEAR III Trial. Neurocrit Care. 2020 02; 32(1):340-347. Porter AL, Ebot J, Lane K, Mooney LH, Lannen AM, Richie EM, Dlugash R, Mayo S, Brott TG, Ziai W, Freeman WD, Hanley DF. PMID: 31571176.
      View in: PubMed   Mentions:
    10. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial. Neurosurgery. 2019 12 01; 85(6):843-853. Polster SP, Stadnik A, Akers AL, Cao Y, Christoforidis GA, Fam MD, Flemming KD, Girard R, Hobson N, Koenig JI, Koskimäki J, Lane K, Liao JK, Lee C, Lyne SB, McBee N, Morrison L, Piedad K, Shenkar R, Sorrentino M, Thompson RE, Whitehead KJ, Zeineddine HA, Hanley DF, Awad IA. PMID: 30476251; PMCID: PMC7054711.
      View in: PubMed   Mentions:
    11. Intracranial Hypertension and Cerebral Perfusion Pressure Insults in Adult Hypertensive Intraventricular Hemorrhage: Occurrence and Associations With Outcome. Crit Care Med. 2019 08; 47(8):1125-1134. Ziai WC, Thompson CB, Mayo S, McBee N, Freeman WD, Dlugash R, Ullman N, Hao Y, Lane K, Awad I, Hanley DF, Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III) Investigato. PMID: 31162192; PMCID: PMC7490004.
      View in: PubMed   Mentions:
    12. Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) Procedure. Neurosurgery. 2019 06 01; 84(6):1157-1168. Awad IA, Polster SP, Carrión-Penagos J, Thompson RE, Cao Y, Stadnik A, Money PL, Fam MD, Koskimäki J, Girard R, Lane K, McBee N, Ziai W, Hao Y, Dodd R, Carlson AP, Camarata PJ, Caron JL, Harrigan MR, Gregson BA, Mendelow AD, Zuccarello M, Hanley DF, MISTIE III Trial Investigators. PMID: 30891610; PMCID: PMC6537634.
      View in: PubMed   Mentions:
    13. Is There a Preferred Incision Location for Nipple-Sparing Mastectomy? A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2019 05; 143(5):906e-919e. Daar DA, Abdou SA, Rosario L, Rifkin WJ, Santos PJ, Wirth GA, Lane KT. PMID: 30789474.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    14. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III). Int J Stroke. 2019 07; 14(5):548-554. Ziai WC, McBee N, Lane K, Lees KR, Dawson J, Vespa P, Thompson RE, Mendelow AD, Kase CS, Carhuapoma JR, Thompson CB, Mayo SW, Reilly P, Janis S, Anderson CS, Harrigan MR, Camarata PJ, Caron JL, Zuccarello M, Awad IA, Hanley DF, MISTIE III Investigators. PMID: 30943878; PMCID: PMC6706298.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    15. Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH). Neurosurgery. 2019 04 01; 84(4):954-964. Polster SP, Cao Y, Carroll T, Flemming K, Girard R, Hanley D, Hobson N, Kim H, Koenig J, Koskimäki J, Lane K, Majersik JJ, McBee N, Morrison L, Shenkar R, Stadnik A, Thompson RE, Zabramski J, Zeineddine HA, Awad IA. PMID: 29660039; PMCID: PMC6500884.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    16. Benign Metastasizing Leiomyoma to the Lung and Spine: A Case Report and Literature Review. Case Rep Oncol. 2019 Jan-Apr; 12(1):218-223. Barber E, Eapen A, Mehta R, Lin E, Lane K, Cheng Y, Parajuli R. PMID: 31011319; PMCID: PMC6465748.
      View in: PubMed   Mentions: 3  
    17. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial. Lancet. 2019 Mar 09; 393(10175):1021-1032. Hanley DF, Thompson RE, Rosenblum M, Yenokyan G, Lane K, McBee N, Mayo SW, Bistran-Hall AJ, Gandhi D, Mould WA, Ullman N, Ali H, Carhuapoma JR, Kase CS, Lees KR, Dawson J, Wilson A, Betz JF, Sugar EA, Hao Y, Avadhani R, Caron JL, Harrigan MR, Carlson AP, Bulters D, LeDoux D, Huang J, Cobb C, Gupta G, Kitagawa R, Chicoine MR, Patel H, Dodd R, Camarata PJ, Wolfe S, Stadnik A, Money PL, Mitchell P, Sarabia R, Harnof S, Barzo P, Unterberg A, Teitelbaum JS, Wang W, Anderson CS, Mendelow AD, Gregson B, Janis S, Vespa P, Ziai W, Zuccarello M, Awad IA, MISTIE III Investigators. PMID: 30739747; PMCID: PMC6894906.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansCTClinical Trials
    18. Symptomatic Hemorrhagic Complications in Clot Lysis: Evaluation of Accelerated Resolution of Intraventricular Hemorrhage Phase III Clinical Trial (CLEAR III): A Posthoc Root-Cause Analysis. Neurosurgery. 2018 12 01; 83(6):1260-1268. Fam MD, Stadnik A, Zeineddine HA, Girard R, Mayo S, Dlugash R, McBee N, Lane K, Mould WA, Ziai W, Hanley D, Awad IA. PMID: 29294116; PMCID: PMC6454794.
      View in: PubMed   Mentions:
    19. African American Screening and Enrollment in (Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage III) CLEAR III. Clin Res (Alex). 2018 Aug; 32(7). Lane K, Keita M, Avadhani R, Dlugash R, Mayo S, Thompson RE, Awad I, McBee N, Ziai W, Hanley DF. PMID: 30221183; PMCID: PMC6138411.
      View in: PubMed   Mentions:
    20. The Incidence of Catheter Tract Hemorrhage and Catheter Placement Accuracy in the CLEAR III Trial. Neurocrit Care. 2018 08; 29(1):23-32. Müller A, Mould WA, Freeman WD, McBee N, Lane K, Dlugash R, Thompson R, Nekoovaght-Tak S, Madan V, Ali H, Stadnik A, Awad I, Hanley D, Ziai WC, CLEAR investigators. PMID: 29294223; PMCID: PMC6086340.
      View in: PubMed   Mentions:
    21. Orbital Metastases from Breast Cancer with BRCA2 Mutation: A Case Report and Literature Review. Case Rep Oncol. 2018 May-Aug; 11(2):360-364. Barber E, Lyou Y, Mehta R, Lin E, Lane K, Parajuli R. PMID: 29983698; PMCID: PMC6031950.
      View in: PubMed   Mentions: 1  
    22. Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms. PLoS One. 2018; 13(5):e0197714. Urrutia VC, Faigle R, Zeiler SR, Marsh EB, Bahouth M, Cerdan Trevino M, Dearborn J, Leigh R, Rice S, Lane K, Saheed M, Hill P, Llinas RH. PMID: 29787575; PMCID: PMC5963768.
      View in: PubMed   Mentions:
    23. Surgical Performance in Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation Phase III Clinical Trial. Neurosurgery. 2017 Nov 01; 81(5):860-866. Fam MD, Hanley D, Stadnik A, Zeineddine HA, Girard R, Jesselson M, Cao Y, Money L, McBee N, Bistran-Hall AJ, Mould WA, Lane K, Camarata PJ, Zuccarello M, Awad IA. PMID: 28402516; PMCID: PMC6257031.
      View in: PubMed   Mentions:
    24. CSF inflammatory response after intraventricular hemorrhage. Neurology. 2017 Oct 10; 89(15):1553-1560. Fam MD, Zeineddine HA, Eliyas JK, Stadnik A, Jesselson M, McBee N, Lane K, Cao Y, Wu M, Zhang L, Thompson RE, John S, Ziai W, Hanley DF, Awad IA, CLEAR III Trial Investigators. PMID: 28887375; PMCID: PMC5634667.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    25. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017 02 11; 389(10069):603-611. Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, Dawson J, Gandhi D, Ullman N, Mould WA, Mayo SW, Mendelow AD, Gregson B, Butcher K, Vespa P, Wright DW, Kase CS, Carhuapoma JR, Keyl PM, Diener-West M, Muschelli J, Betz JF, Thompson CB, Sugar EA, Yenokyan G, Janis S, John S, Harnof S, Lopez GA, Aldrich EF, Harrigan MR, Ansari S, Jallo J, Caron JL, LeDoux D, Adeoye O, Zuccarello M, Adams HP, Rosenblum M, Thompson RE, Awad IA, CLEAR III Investigators. PMID: 28081952; PMCID: PMC6108339.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCTClinical Trials
    26. Participation of a coordinating center pharmacy in a multicenter international study. Am J Health Syst Pharm. 2016 Nov 15; 73(22):1859-1868. Jeon JE, Mighty J, Lane K, McBee N, Majkowski R, Mayo S, Hanley D. PMID: 27821398; PMCID: PMC6188656.
      View in: PubMed   Mentions:
    27. Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trial. Lancet Neurol. 2016 Nov; 15(12):1228-1237. Hanley DF, Thompson RE, Muschelli J, Rosenblum M, McBee N, Lane K, Bistran-Hall AJ, Mayo SW, Keyl P, Gandhi D, Morgan TC, Ullman N, Mould WA, Carhuapoma JR, Kase C, Ziai W, Thompson CB, Yenokyan G, Huang E, Broaddus WC, Graham RS, Aldrich EF, Dodd R, Wijman C, Caron JL, Huang J, Camarata P, Mendelow AD, Gregson B, Janis S, Vespa P, Martin N, Awad I, Zuccarello M, MISTIE Investigators. PMID: 27751554; PMCID: PMC5154627.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCTClinical Trials
    28. ICES (Intraoperative Stereotactic Computed Tomography-Guided Endoscopic Surgery) for Brain Hemorrhage: A Multicenter Randomized Controlled Trial. Stroke. 2016 11; 47(11):2749-2755. Vespa P, Hanley D, Betz J, Hoffer A, Engh J, Carter R, Nakaji P, Ogilvy C, Jallo J, Selman W, Bistran-Hall A, Lane K, McBee N, Saver J, Thompson RE, Martin N, ICES Investigators. PMID: 27758940; PMCID: PMC6168060.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    29. Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena). Clin Breast Cancer. 2016 10; 16(5):356-363. Ganz PA, Hahn EE, Petersen L, Melisko ME, Pierce JP, Von Friederichs-Fitzwater M, Lane KT, Hiatt RA. PMID: 27397694; PMCID: PMC5056127.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Early Therapy Intensity Level (TIL) Predicts Mortality in Spontaneous Intracerebral Hemorrhage. Neurocrit Care. 2015 Oct; 23(2):188-97. Ziai WC, Siddiqui AA, Ullman N, Herrick DB, Yenokyan G, McBee N, Lane K, Hanley DF. PMID: 26025213.
      View in: PubMed   Mentions:
    31. Bleeding and infection with external ventricular drainage: a systematic review in comparison with adjudicated adverse events in the ongoing Clot Lysis Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III (CLEAR-III IHV) trial. Neurosurgery. 2015 Mar; 76(3):291-300; discussion 301. Dey M, Stadnik A, Riad F, Zhang L, McBee N, Kase C, Carhuapoma JR, Ram M, Lane K, Ostapkovich N, Aldrich F, Aldrich C, Jallo J, Butcher K, Snider R, Hanley D, Ziai W, Awad IA, CLEAR III Trial Investigators. PMID: 25635887; PMCID: PMC4333009.
      View in: PubMed   Mentions:
    32. Does immediate tissue expander placement increase immediate postoperative complications in patients with breast cancer? Am Surg. 2015 Feb; 81(2):143-9. Masoomi H, Paydar KZ, Evans GR, Tan E, Lane KT, Wirth GA. PMID: 25642875.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy. Am Surg. 2014 Oct; 80(10):940-3. Bonev V, Evangelista M, Chen JH, Su MY, Lane K, Mehta R, Butler J, Hsiang D. PMID: 25264634; PMCID: PMC4343309.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    34. A randomized prospective study of lumpectomy margin assessment with use of MarginProbe in patients with nonpalpable breast malignancies. Ann Surg Oncol. 2014 May; 21(5):1589-95. Schnabel F, Boolbol SK, Gittleman M, Karni T, Tafra L, Feldman S, Police A, Friedman NB, Karlan S, Holmes D, Willey SC, Carmon M, Fernandez K, Akbari S, Harness J, Guerra L, Frazier T, Lane K, Simmons RM, Estabrook A, Allweis T. PMID: 24595800; PMCID: PMC3975090.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    35. Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology. J Surg Oncol. 2014 Feb; 109(2):158-67. Chen JH, Bahri S, Mehta RS, Carpenter PM, McLaren CE, Chen WP, Fwu PT, Hsiang DJ, Lane KT, Butler JA, Su MY. PMID: 24166728; PMCID: PMC4005994.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    36. A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke. 2014 Jun; 9(4):536-42. Ziai WC, Tuhrim S, Lane K, McBee N, Lees K, Dawson J, Butcher K, Vespa P, Wright DW, Keyl PM, Mendelow AD, Kase C, Wijman C, Lapointe M, John S, Thompson R, Thompson C, Mayo S, Reilly P, Janis S, Awad I, Hanley DF, CLEAR III Investigators. PMID: 24033910; PMCID: PMC6931254.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    37. Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project. J Cancer Surviv. 2013 Sep; 7(3):323-30. Hahn EE, Ganz PA, Melisko ME, Pierce JP, von Friederichs-Fitzwater M, Lane KT, Hiatt RA. PMID: 23494652; PMCID: PMC3723743.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    38. Can regional tattoos impact sentinel lymph node identification? Am Surg. 2013 Mar; 79(3):331-2. Datrice N, Wirth G, Hsiang D, Butler J, Lane KT. PMID: 23461966.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke. 2013 Mar; 44(3):627-34. Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA, Bistran-Hall AJ, Ullman NL, Vespa P, Martin NA, Awad I, Zuccarello M, Hanley DF, MISTIE Investigators. PMID: 23391763; PMCID: PMC4124642.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansCTClinical Trials
    40. The Modified Graeb Score: an enhanced tool for intraventricular hemorrhage measurement and prediction of functional outcome. Stroke. 2013 Mar; 44(3):635-41. Morgan TC, Dawson J, Spengler D, Lees KR, Aldrich C, Mishra NK, Lane K, Quinn TJ, Diener-West M, Weir CJ, Higgins P, Rafferty M, Kinsley K, Ziai W, Awad I, Walters MR, Hanley D, CLEAR and VISTA Investigators. PMID: 23370203; PMCID: PMC6800016.
      View in: PubMed   Mentions:
    41. Occurrence and impact of intracranial pressure elevation during treatment of severe intraventricular hemorrhage. Crit Care Med. 2012 May; 40(5):1601-8. Ziai WC, Melnychuk E, Thompson CB, Awad I, Lane K, Hanley DF. PMID: 22430237; PMCID: PMC4365868.
      View in: PubMed   Mentions:
    42. Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile. Clin Breast Cancer. 2012 Apr; 12(2):110-8. Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY. PMID: 22444717; PMCID: PMC3342312.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    43. Factors affecting clot lysis rates in patients with spontaneous intraventricular hemorrhage. Stroke. 2012 May; 43(5):1234-9. Ziai WC, Muschelli J, Thompson CB, Keyl PM, Lane K, Shao S, Hanley DF. PMID: 22382155; PMCID: PMC6290679.
      View in: PubMed   Mentions:
    44. Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group. Stroke. 2011 Dec; 42(12):3631-3. Herrick DB, Ziai WC, Thompson CB, Lane K, McBee NA, Hanley DF. PMID: 21940973; PMCID: PMC3233723.
      View in: PubMed   Mentions:
    45. Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging. Radiology. 2011 Dec; 261(3):735-43. Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY. PMID: 21878615; PMCID: PMC3219909.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    46. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the intraventricular hemorrhage thrombolysis trial. Stroke. 2011 Nov; 42(11):3009-16. Naff N, Williams MA, Keyl PM, Tuhrim S, Bullock MR, Mayer SA, Coplin W, Narayan R, Haines S, Cruz-Flores S, Zuccarello M, Brock D, Awad I, Ziai WC, Marmarou A, Rhoney D, McBee N, Lane K, Hanley DF. PMID: 21868730; PMCID: PMC3356690.
      View in: PubMed   Mentions:
    47. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008 Dec; 207(6):928-34. Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS. PMID: 19183541.
      View in: PubMed   Mentions: 171     Fields:    Translation:Humans
    48. Regional differences in the use of sentinel lymph node biopsy for melanoma: a potential quality measure. Am Surg. 2008 Oct; 74(10):981-4. Lane K, Kempf A, Magno C, Lane J, Butler J, Hsiang D, Greenfield S, Jakowatz J. PMID: 18942627.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    49. Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg. 2008 Oct; 48(4):897-904. Lane JS, Magno CP, Lane KT, Chan T, Hoyt DB, Greenfield S. PMID: 18586439.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    50. The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy. Am Surg. 2007 Oct; 73(10):977-80. Yamamoto M, Mehta RS, Baick CH, Su MY, Lane KT, Butler JA, Hsiang DJ. PMID: 17983061.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    51. Do breast columnar cell lesions with atypia need to be excised? Am Surg. 2007 Oct; 73(10):984-6. Datrice N, Narula N, Maggard M, Butler J, Hsiang D, Baick C, Lane K. PMID: 17983063.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    52. Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab. Arch Surg. 2007 Sep; 142(9):855-61; discussion 860-1. Hsiang DJ, Yamamoto M, Mehta RS, Su MY, Baick CH, Lane KT, Butler JA. PMID: 17875840.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    53. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002. J Vasc Surg. 2006 Aug; 44(2):319-24; discussion 324-5. Lane JS, Vittinghoff E, Lane KT, Hiramoto JS, Messina LM. PMID: 16890861.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    54. Primary tumor characteristics predict sentinel lymph node macrometastasis in breast cancer. Breast J. 2005 Sep-Oct; 11(5):338-43. Tan YY, Wu CT, Fan YG, Hwang S, Ewing C, Lane K, Esserman L, Lu Y, Treseler P, Morita E, Leong SP. PMID: 16174155.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    55. Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. Arch Surg. 2005 Feb; 140(2):196-8; discussion 199-200. Foster RD, Hansen SL, Esserman LJ, Hwang ES, Ewing C, Lane K, Anthony JP. PMID: 15724003.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    56. Accuracy of selective sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg. 2004 Dec; 199(6):856-62. Lang JE, Esserman LJ, Ewing CA, Rugo HS, Lane KT, Leong SP, Hwang ES. PMID: 15555967.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    Karen's Networks
    Concepts (216)
    Derived automatically from this person's publications.
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _